This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Pacific Biosciences Increases Sequencing Performance Of The PacBio RS With Introduction Of The Automated MagBead Station

Stocks in this article: PACB

MENLO PARK, Calif., Sept. 19, 2012 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) provider of the PacBio ® RS High Resolution Genetic Analyzer, today announced the launch of the MagBead Station for the PacBio RS, a product enhancement that delivers more high-value long reads, enables use of small sample amounts, and makes sample preparation more robust.

The MagBead Station upgrade and associated MagBead kit enable sequencing of longer templates, especially for samples that are biologically difficult to prepare. This results in more 4-10 kilobase long reads captured with each SMRT ® Cell.  Because the process is more robust, sequencing results have higher overall consistency. It also significantly reduces the amount of the input sample required, which can be critical for experiments when there is a small amount of useable DNA available from a sample.

The Broad Institute is among the PacBio customers that had early access to test the MagBead Station upgrade. "Initial runs using the MagBead Station on the PacBio RS look very promising," said Chad Nusbaum, Ph.D., Scientific Director of Broad Technology Labs at the Broad Institute. "The MagBead Station greatly reduces any adapter-dimer that may be present in some libraries and there are clearly benefits in terms of how much library is consumed during loading a sequencing run. Compared to diffusion loading, approximately one-tenth the library is needed to load each SMRT Cell, allowing us to contemplate much deeper sequence coverage from a single library preparation."

"This upgrade is consistent with our intention to provide continuous ongoing improvements to the PacBio RS. With this latest enhancement, we expect our customers will be able to generate 10 kilobase-size libraries using as little as one microgram of sample, a five to 10-fold improvement from where we were just a few months ago," said Michael Hunkapiller, Ph.D. President and Chief Executive Officer of Pacific Biosciences. "We expect that our automated MagBead Station will make a substantial difference in customers' ability to run experiments on challenging samples because it will reduce the impact of the variability in sample prep while reducing the amount of sample needed to perform highly accurate sequencing."

The upgrade is being provided to current customers and will be directly integrated into the PacBio RS for new customers. For more information about Pacific Biosciences, please visit www.pacb.com

About Pacific Biosciences

Pacific Biosciences of California, Inc. (Nasdaq:PACB) offers the PacBio ® RS High Resolution Genetic Analyzer to help scientists solve genetically complex problems.  Based on its novel Single Molecule, Real-Time (SMRT ®) technology, the company's products enable: targeted sequencing to more comprehensively characterize genetic variations; de novo genome assembly to more fully identify, annotate and decipher genomic structures; and DNA base modification identification to help characterize epigenetic regulation and DNA damage. By providing access to information that was previously inaccessible, Pacific Biosciences enables scientists to increase their understanding of biological systems.

CONTACT: Media:
         Maurissa Messier
         For Pacific Biosciences
         760.539.7417
         maurissa@bioscribe.com
         
         Investors:
         Trevin Rard
         Pacific Biosciences
         650.521.8450
         ir@pacificbiosciences.com

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs